S&P Futures
4,148.00 +6.25 (+0.15%) Dow Futures
32,840.00 +48.00 (+0.15%) Nasdaq Futures
13,199.00 +15.75 (+0.12%) Russell 2000 Futures
1,944.90 +3.80 (+0.20%) Crude Oil
90.86 +0.10 (+0.11%) Gold
1,802.50 -2.70 (-0.15%)
ResMed Inc. (RSMDF)
Chart Events
Performance Outlook
| Previous Close | 24.00 |
| Open | 24.00 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 24.00 - 24.00 |
| 52 Week Range | 1.90 - 29.74 |
| Volume | |
| Avg. Volume | 1,200 |
| Market Cap | 35.835B |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | 28.14 |
| EPS (TTM) | 0.85 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.17 (0.70%) |
| Ex-Dividend Date | May 11, 2022 |
| 1y Target Est | 11.49 |
- Simply Wall St.
Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 252% gain
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
- Zacks
NuVasive (NUVA) Lags Q2 Earnings Estimates
NuVasive (NUVA) delivered earnings and revenue surprises of -14.55% and 1.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germanysomnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care gap and providing alternative to prevailing drug therapy mementor to be integrated into ResMed in Germany as a separate business segment and will serve as a platform for further developments in the field of digital health MARTINSRIED, Germany and LEIPZIG, Germany, Aug. 02, 2022 (GLOBE NEWSWIRE) -- R
